STIM
Neuronetics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$2.88
+5.88%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.30x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 12.29x
- Price / sales
- 1.41x
- Price / cash flow
- -24.04x
Enterprise value
- Enterprise value
- $290.3M
- EV / sales
- 1.87x
- EV / EBITDA
- -13.66x
- EV / EBIT
- -12.70x
- Market cap
- $219.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026